| Today's Open | $55.48 |
|---|---|
| Previous Close | $54.96 |
| Daily Range | $54.65 - $56.43 |
| 52-Week Range | $24.12 - $57.10 |
| Market Cap | $85.9B |
| P/E Ratio | 30.70 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 13,909,463 |
| Average Daily Volume | 13,370,117 |
| Current FY EPS | $1.90 |
Sector
Healthcare
Industry
Drugs
Gilead Sciences (GILD) Description
Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/
News & Commentary
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Cancer research is big business, and it pays to know where research dollars are headed.3 Horrendous Health-Care Stocks This Week
The rising tide of the stock market didn't lift all boats.Cancer Meeting Highlights the Good and Bad of the Immune System
The immune system can kill tumors, but it can also go haywire.GILD's Top Competitors
(2.44%)
(0.63%)
(1.16%)
